TowardPi (Beijing) Medical Technology Ltd, a Chinese medical technology company, has reportedly secured RMB 200 million in a Series D financing round. The round was led by Matrix Partners, with participation from GTJA Investment and other investors.
Established in 2017, TowardPi Medical’s core technical team comprises numerous graduates from Tsinghua University, and its core technology is derived from the transformation of Tsinghua’s scientific and technological achievements.
According to a report by Frost & Sullivan, in 2023, TowardPi Medical’s ophthalmic over-the-counter (OCT) products held a 27% market share in public hospitals, leading the domestic market in China.- Flcube.com
